Harlow, United Kingdom

Robert James Gleave

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Location History:

  • Harlow, GB (2011 - 2013)
  • Cambridge, GB (2015 - 2017)

Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Work of Inventor Robert James Gleave

Introduction:

Robert James Gleave, a talented inventor hailing from Harlow, GB, has made significant contributions to the field with a total of 8 patents to his name. His groundbreaking research has focused on the development of novel tetrazole compounds as calcium channel blockers, paving the way for advancements in therapeutic treatments.

Latest Patents:

His latest patents revolve around tetrazole compounds as calcium channel blockers. These compounds, encompassed by Formula (I) with various A structures, have shown promising potential in treating diseases that benefit from the blocking of Ca2.2 calcium channels.

Career Highlights:

Throughout his career, Robert James Gleave has lent his expertise to esteemed companies such as Convergence Pharmaceuticals Limited and Glaxo Group Limited. Within these organizations, he has spearheaded research projects that have garnered recognition within the scientific community for their innovative approaches and practical applications.

Collaborations:

Notable colleagues who have had the privilege of working alongside Robert James Gleave include Paul John Beswick and Sadie Vile. Together, they have formed dynamic teams that have brought forth pioneering ideas and transformed them into tangible inventions.

Conclusion:

In conclusion, Robert James Gleave stands out as a visionary inventor whose dedication to pushing the boundaries of scientific discovery has resulted in a series of impactful patents. His relentless pursuit of innovation serves as an inspiration to aspiring inventors and underscores the importance of creativity in driving progress within the realm of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…